Concepedia
Author
Gala Vega
Also Known As
19
Publications
105
Citations
5
H-Index
0
Concepts
All Affiliations
×
All Concepts
93
First-in-human study of JNJ-79635322 (JNJ-5322), a novel, next-generation trispecific antibody (TsAb), in patients (pts) with relapsed/refractory multiple myeloma (RRMM): Initial phase 1 results.
Niels W.C.J. van de Donk, Gala Vega, Aurore Perrot, +17
Journal of Clinical Oncology
2025
25
Phase 1b Study of Menin-KMT2A Inhibitor Bleximenib in Combination with Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia with <i>KMT2Ar</i> or <i>NPM1</i> Alterations
Christian Récher, Jenny O’Nions, Ibrahim Aldoss, +53
Blood
2024
21
Cut-Off Values of Hematologic Parameters to Predict the Number of Alpha Genes Deleted in Subjects with Deletional Alpha Thalassemia
Diego Velasco‐Rodríguez, Carlos Blas, Juan Manuel Alonso‐Domínguez, +4
International Journal of Molecular Sciences
2017
20
Impact of Prior Bendamustine Exposure on Bispecific Antibody Treatment Outcomes for Patients with B-Cell Lymphoma
Gloria Iacoboni, Ángel Serna, Victor Navarro Garcés, +15
2023
14
CDK9 INHIBITORS: a promising combination partner in the treatment of hematological malignancies
Daniel Morillo, Gala Vega, Víctor Moreno
Oncotarget
13
Page 1